<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04394052</url>
  </required_header>
  <id_info>
    <org_study_id>2019PI253</org_study_id>
    <nct_id>NCT04394052</nct_id>
  </id_info>
  <brief_title>Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II</brief_title>
  <acronym>TUMOSTEO II</acronym>
  <official_title>Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II: Texture Analysis and Artificial Intelligence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lorraine Cancer Institute - ICL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emille Gallé Surgical Center - CCEG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Diagnostic and Interventional Adaptative Imaging Laboratory - IADI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nancy's Regional University Hospital Center (CHRU-Nancy) anatomopathology department</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at evaluating the value of various artificial intelligence based techniques
      to improve the characterization and image post-processing for patients with musculoskeletal
      tumors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of values relating to the texture parameters of tumors evaluated by MRI and
      ultra-high resolution CT between benign and malignant lesions using histological analysis as
      the standard of reference.

      Comparison of the diagnostic performance of texture parameters derived from different MRI
      sequences and ultra-high resolution CT for musculoskeletal tumor characterization.

      Evaluate the impact of ultra-high resolution with respect to standard resolution on CT images
      Comparison of the diagnostic performance of the texture parameters for the tumor on the
      diagnostic performance of texture analysis derived parameters for the characterization of
      musculoskeletal tumors.

      Evaluate the effectiveness and accuracy of automatic artificial intelligence (AI) based tumor
      segmentation tools.

      Evaluate the use of trabecular analysis on ultra-high resolution CT images for the evaluation
      of tumor-bone interfaces.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2030</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lesion benignancy or malignancy</measure>
    <time_frame>Performed up to 6 months after CT and Magnetic Resonance (MR) imaging</time_frame>
    <description>Histologic determination of lesion aggressiveness (benign versus malignant) on core biopsy material</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sarcoma FNCLCC (fédération Nationale des Centres de Lutte Contre le Cancer) grade</measure>
    <time_frame>Performed up to 1 year after CT and MR imaging</time_frame>
    <description>Histologic grade of the sarcomas included in the study population with surgical resection material</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">740</enrollment>
  <condition>Soft Tissue Neoplasm</condition>
  <condition>Bone Neoplasm</condition>
  <arm_group>
    <arm_group_label>Soft-tissue tumors</arm_group_label>
    <description>Benign and malignant soft tissue masses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bone tumors</arm_group_label>
    <description>Benign and malignant bone focal bone lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MR imaging</intervention_name>
    <description>Medical imaging</description>
    <arm_group_label>Bone tumors</arm_group_label>
    <arm_group_label>Soft-tissue tumors</arm_group_label>
    <other_name>Ultra-high resolution CT</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with soft-tissue and bone tumors evaluated with MR and ultra-high resolution CT.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suspected to have a bone or soft-tissue tumor referred for imaging for
             initial tumors characterization and staging.

        Exclusion Criteria:

          -  Pregnancy

          -  Breast feeding patients

          -  Renal insufficiency

          -  Contra indications to MRI or CT

          -  Prior surgery or treatment to the evaluated lesion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pedro Gondim Teixieira, PhD</last_name>
    <phone>+33 3 83 85 21 61</phone>
    <email>p.teixeira@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela Hossu, PhD</last_name>
    <phone>+33 3 83 15 50 96</phone>
    <email>g.hossu@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU-Nancy</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Gondim Teixeira, Prof</last_name>
      <phone>+33383852161</phone>
      <email>p.teixeira@chru-nancy.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alain Blum, Prof</last_name>
      <phone>+33383852161</phone>
      <email>alain.blum@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 12, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>CT</keyword>
  <keyword>Texture analysis</keyword>
  <keyword>Ultra-high resolution</keyword>
  <keyword>Tumors</keyword>
  <keyword>Musculoskeletal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Soft Tissue Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

